New Orforglipron Pill for Obesity: Promising Results

A new pill with the active ingredient Orforglipron shows significant results in the treatment of obesity, according to initial data. The oral treatment appears to reduce body weight and control blood sugar.

GLP-1 hormone-based therapies have already changed the approach to obesity and type 2 diabetes by regulating appetite and improving glucose control. Until now, the most effective treatments were injectable, which the new therapy aims to change.

Studies show significant weight loss and improvement in metabolic markers with the use of the pill. The most common side effects relate to the gastrointestinal system, such as nausea. Experts emphasize that treatment should be combined with lifestyle changes, such as a balanced diet and exercise.

Associate Professor Martin Whyte points out that the new therapy may broaden access to treatment for those who struggle with injections, but further research is needed.

Source: ygeiamou.gr